| scholarly article | Q13442814 |
| P50 | author | Arkadeep Sinha | Q85118397 |
| P2093 | author name string | Brian B Haab | |
| Michael T Barrett | |||
| Elizabeth Lenkiewicz | |||
| David Cherba | |||
| Lisa Evers | |||
| Heather Bartlam | |||
| P2860 | cites work | A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells | Q24307672 |
| KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas | Q24307815 | ||
| Lef-1 isoforms regulate different target genes and reduce cellular adhesion | Q24321215 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| Distant metastasis occurs late during the genetic evolution of pancreatic cancer | Q24624284 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. | Q27851466 | ||
| SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer | Q27851475 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene | Q28273369 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome | Q28283932 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma | Q28300339 | ||
| Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems | Q28475586 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
| EMT and dissemination precede pancreatic tumor formation | Q29615854 | ||
| Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 | ||
| Glycoprotein glycosylation and cancer progression | Q33783686 | ||
| ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma | Q33939548 | ||
| Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells | Q33945484 | ||
| SMURF1 amplification promotes invasiveness in pancreatic cancer | Q34009701 | ||
| Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival | Q34465346 | ||
| Molecular mechanisms of epithelial morphogenesis | Q34762520 | ||
| High-resolution characterization of the pancreatic adenocarcinoma genome | Q34834994 | ||
| Genome-wide analysis of pancreatic cancer using microarray-based techniques | Q34902717 | ||
| Pancreatic cancer biology and genetics | Q35013204 | ||
| Advancing a clinically relevant perspective of the clonal nature of cancer | Q35123202 | ||
| Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer | Q35230326 | ||
| Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease | Q35745828 | ||
| Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations | Q37000267 | ||
| Biomarkers for epithelial-mesenchymal transitions | Q37209254 | ||
| Molecular markers in pancreatic cancer diagnosis. | Q38073024 | ||
| CD49f-positive cell population efficiently enriches colon cancer-initiating cells | Q39147242 | ||
| Methylation status of TUSC3 is a prognostic factor in ovarian cancer | Q39253858 | ||
| Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array | Q39858190 | ||
| Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer | Q39895055 | ||
| Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells | Q40105497 | ||
| Expression of snail in pancreatic cancer promotes metastasis and chemoresistance | Q40116866 | ||
| Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition | Q40169788 | ||
| In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. | Q40290489 | ||
| Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells | Q40373981 | ||
| Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer | Q40394988 | ||
| Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines | Q40404488 | ||
| Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines | Q40414760 | ||
| High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer | Q40490949 | ||
| Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes | Q40539686 | ||
| Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines | Q40559191 | ||
| Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma | Q40919845 | ||
| Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1alpha stimulation | Q41052638 | ||
| Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents | Q41070801 | ||
| Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas | Q41148624 | ||
| Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma. | Q41584569 | ||
| Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma | Q41649976 | ||
| c-Met in pancreatic cancer stem cells: therapeutic implications. | Q42426376 | ||
| Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer | Q42631961 | ||
| Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. | Q42799642 | ||
| Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications | Q42801596 | ||
| Newly established human pancreatic carcinoma cell lines and their lectin binding properties. | Q42810312 | ||
| E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells | Q43107815 | ||
| BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
| Sarcoglycans in the normal and pathological breast tissue of humans: an immunohistochemical and molecular study. | Q45390318 | ||
| N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma | Q47290074 | ||
| Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. | Q54445461 | ||
| Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer | Q57274830 | ||
| Adaptation to culture of human embryonic stem cells and oncogenesis in vivo | Q59544319 | ||
| Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes | Q60531736 | ||
| Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer | Q72092571 | ||
| p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma | Q73424501 | ||
| Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer | Q79977850 | ||
| P433 | issue | 7 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 1253-1265 | |
| P577 | publication date | 2014-05-02 | |
| P1433 | published in | Molecular Oncology | Q2190736 |
| P1476 | title | Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts | |
| P478 | volume | 8 |
Search more.